Subclinical atherosclerosis and serum lipid levels in relation to ultrasonographic enthesopathy in psoriasis patients, a single-center and comparative cross-sectional study

Mowlika Muppalla; Vijaya Prasanna Parimi; K. Kiran Kumar Reddy

doi:10.18203/issn.2455-4529.IntJResDermatol20253394

Authors

Mowlika Muppalla Department of Clinical Immunology and Rheumatology, ESIC Medical College and Super Speciality Hospital, Hyderabad, Telangana, India
Vijaya Prasanna Parimi Department of Clinical Immunology and Rheumatology, ESIC Medical College and Super Speciality Hospital, Hyderabad, Telangana, India
K. Kiran Kumar Reddy Department of Radiology, ESIC Medical College and Super Speciality Hospital, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20253394

Keywords:

Carotid intima media thickness, Cardiovascular risk, Enthesitis, Dyslipidemias, Psoriatic arthritis

Abstract

Background: Psoriasis is a chronic autoimmune skin disorder characterised by persistent oxidative stress and elevated serum lipid levels, which are risk factors for atherosclerosis. Carotid intima-media thickness (CIMT) is a validated measure of subclinical atherosclerosis, while chronic inflammation in psoriasis may contribute to both entheseal and vascular pathology. Hence, this study was aimed to evaluate subclinical atherosclerosis using CIMT, serum lipid levels and their correlation with ultrasonographic enthesopathy in psoriasis patients without musculoskeletal symptoms.

Methods: A single-centred, comparative cross-sectional study was conducted, including 80 psoriasis patients without musculoskeletal symptoms or comorbidities and 80 age- and sex-matched healthy controls. Demographic parameters, Psoriasis Area and Severity Index (PASI), body mass index (BMI), and serum lipid profiles (total cholesterol, LDL, HDL, VLDL, triglycerides) were assessed. Ultrasonographic CIMT and entheseal sites were evaluated using OMERACT ultrasound consensus criteria. Entheseal scores were correlated with CIMT, BMI, and lipid levels, and results were compared between groups using the standard t-test.

Results: Psoriasis patients (mean age: 41.56 years; mean disease duration: 5.85 years) showed significantly higher mean CIMT, LDL, VLDL, and total entheseal scores compared to controls (p<0.05). Ultrasonographic entheseal inflammation scores significantly correlated with serum triglycerides, LDL, VLDL, and CIMT, while entheseal structural scores correlated with LDL, VLDL, and CIMT (p<0.05).

Conclusions: Subclinical atherosclerosis, serum lipid levels, and ultrasonographic entheseal abnormalities in psoriasis patients are significantly associated, reflecting a heightened inflammatory burden that links vascular and entheseal pathologies. These findings emphasise the need for integrated cardiovascular and musculoskeletal monitoring in psoriasis management.

Metrics

Metrics Loading ...

References

Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Ind Dermatol Online J. 2016;7(6):471-80. DOI: https://doi.org/10.4103/2229-5178.193906

Ramonda R, Nigro AL, Modesti V, Nalotto L, Musacchio E, Iaccarino L, et al. Atherosclerosis in psoriatic arthritis. Autoimmu Revi. 2011;10(12):773-8. DOI: https://doi.org/10.1016/j.autrev.2011.05.022

de Aragón CA, Berna-Rico E, Ballester-Martinez MA, Jaén P, Solís J, Barderas MG, et al. Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP): protocol for an observational, single-centre, prospective cohort study. BMJ open. 2023;13(9):e072455. DOI: https://doi.org/10.1136/bmjopen-2023-072455

Patt YS, Watad A, Giovannini I, Abu-Obeida WH, Errichetti E, David P, et al. Risk factors for psoriatic arthritis development in psoriasis patients: Myths, pitfalls, and pearls. Clin. Exp. Rheumatol. 2024;42:1856-66. DOI: https://doi.org/10.55563/clinexprheumatol/h6176m

McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of a “synovioentheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007;56:2482-91. DOI: https://doi.org/10.1002/art.22758

Kawai K, Finn AV, Virmani R. Subclinical atherosclerosis: part 1: what is it? can it be defined at the histological level?. Arteriosc Thrombos Vasc Biol. 2024;44(1):12-23. DOI: https://doi.org/10.1161/ATVBAHA.123.319932

Wang Y, Zang J, Liu C, Yan Z, Shi D. Interleukin-17 links inflammatory cross-talks between comorbid psoriasis and atherosclerosis. Fronti Immunol. 2022;13:835671. DOI: https://doi.org/10.3389/fimmu.2022.835671

Gutierrez M, Filippucci E, De Angelis R, Salaffi F, Filosa G, Ruta S, et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40(5):407-12. DOI: https://doi.org/10.1016/j.semarthrit.2010.05.009

Aissa RB, Boussaid S, Rekik S, Rahmouni S, Jemmali S, Ajlani H, et al. AB0950 Detection of asymptomatic entheseal involvement in patients with psoriasis: A case-control ultrasound study. Ann Rheumat Dis. 2022;81:1603. DOI: https://doi.org/10.1136/annrheumdis-2022-eular.4054

Helliwell PS. Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting. J Rheumatol. 2011;38(3):551-2. DOI: https://doi.org/10.3899/jrheum.101119

Balint PV, Terslev L, Aegerter P, Bruyn GA, Chary-Valckenaere I, Gandjbakhch F, et al. Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative. Ann Rheum Dis. 2018;77(12):1730-5. DOI: https://doi.org/10.1136/annrheumdis-2018-213609

Balci DD, Balci A, Karazincir Sİ, Ucar ED, Iyigun U, Yalcin FA, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Euro Aca Dermatol Venereol. 2009;23(1). DOI: https://doi.org/10.1111/j.1468-3083.2008.02936.x

Yiu KH, Yeung CK, Zhao CT, Chan JC, Siu CW, Tam S, et al. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis. J Inter Medi. 2013;273(3):273-82. DOI: https://doi.org/10.1111/joim.12002

Evensen K, Slevolden E, Skagen K, Rønning OM, Brunborg C, Krogstad AL, et al. Increased subclinical atherosclerosis in patients with chronic plaque psoriasis. Atheroscl. 2014;237(2):499-503. DOI: https://doi.org/10.1016/j.atherosclerosis.2014.10.008

El‐Mongy S, Fathy H, Abdelaziz A, Omran E, George S, Neseem N, et al. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Euro Acad Dermatol Venereol. 2010;24(6):661-6. DOI: https://doi.org/10.1111/j.1468-3083.2009.03481.x

Enany B, El Zohiery AK, Elhilaly R, Badr T. Karotis-Intima-Media-Dicke und Serumleptin bei Psoriasis. Herz. 2012;37:527-33. DOI: https://doi.org/10.1007/s00059-011-3547-z

Piskin S, Gurkok F, Ekuklu G, Senol M. Serum lipid levels in psoriasis. Yonsei Medi J. 2003;44(1):24-6. DOI: https://doi.org/10.3349/ymj.2003.44.1.24

Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica Chim Acta. 2001;303(1-2):33-9. DOI: https://doi.org/10.1016/S0009-8981(00)00358-2

Uyanik BS, Ari Z, Onur E, Gündüz K, Tanülkü S, Durkan K. Serum lipids and apolipoproteins in patients with psoriasis. De Gru. 2005;40(1). DOI: https://doi.org/10.1515/CCLM.2002.013

Bajaj DR, Mahesar SM, Devrajani BR, Iqbal MP. Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad. JPMA. J Pak Med Associa. 2009;59(8):512-5.

Nakhwa YC, Rashmi R, Basavaraj KH. Dyslipidemia in psoriasis: a case controlled study. Int Sch Res Noti. 2014;2014(1):729157. DOI: https://doi.org/10.1155/2014/729157

Vyas K, Jain SK, Mittal A, Kumar R, Saxena S, Malviya S. Sonographic evaluation of subclinical enthesopathy in patients of chronic plaque psoriasis. Ind Dermatol Online J. 2020;11(4):580-5. DOI: https://doi.org/10.4103/idoj.IDOJ_446_18

Gisondi P, Tinazzi I, El-Dalati G, Gallo M, Biasi D, Barbara LM et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study. Ann Rheum Dis. 2008;67(1):26-30. DOI: https://doi.org/10.1136/ard.2007.075101

Naredo E, Möller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E, et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatol. 2011;50(10):1838-48. DOI: https://doi.org/10.1093/rheumatology/ker078

Huong NT, Long B, Doanh LH, Thoai TM, Hang NT, Khoi L, et al. Associations of different inflammatory factors with atherosclerosis among patients with psoriasis vulgaris. Front Medi. 2024;11:1396680. DOI: https://doi.org/10.3389/fmed.2024.1396680

Elsayed EK, El-Saadany HM, Elfar NN, El-Khouly RM, Almaidany SH, Gaber RA. Association of interleukin-17 with peripheral spondyloarthropathic changes detected by musculoskeletal ultrasound in psoriatic patients. Egypt Rheumatol. 2020;42(4):303-7. DOI: https://doi.org/10.1016/j.ejr.2019.04.011